The authors describe a proprietary process for producing a stable, topical interferon alpha-2b formulation that can deliver large drug molecules into the skin or mucosa.
Ravinderjit Batta
Advertisement
Ravinderjit Batta, M. Pharm., is group leader of formulation development at Helix BioPharma.
Articles by Ravinderjit Batta
Advertisement
Latest Updated Articles
Stabilization of Interferon alpha-2b in a Topical CreamPublished: July 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
4
Best Practices for AI Adoption in Pharmaceutical Research
5
